RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 103 filers reported holding RAPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.07 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,833 | -9.8% | 3,539,841 | +1.5% | 0.01% | 0.0% |
| Q2 2023 | $65,222 | +7.2% | 3,487,753 | +5.2% | 0.01% | 0.0% |
| Q1 2023 | $60,848 | -8.7% | 3,315,870 | -1.5% | 0.01% | -18.2% |
| Q4 2022 | $66,625 | -99.9% | 3,364,887 | +9.3% | 0.01% | -8.3% |
| Q3 2022 | $74,099,000 | -6.3% | 3,079,742 | -29.0% | 0.01% | +20.0% |
| Q2 2022 | $79,108,000 | -9.5% | 4,334,683 | +9.1% | 0.01% | +11.1% |
| Q1 2022 | $87,404,000 | -39.7% | 3,974,705 | +0.7% | 0.01% | -30.8% |
| Q4 2021 | $144,998,000 | +19.7% | 3,947,685 | +1.2% | 0.01% | +18.2% |
| Q3 2021 | $121,163,000 | +6.1% | 3,902,178 | +8.6% | 0.01% | 0.0% |
| Q2 2021 | $114,234,000 | +99.5% | 3,593,399 | +39.3% | 0.01% | +83.3% |
| Q1 2021 | $57,273,000 | +12.2% | 2,579,846 | -0.2% | 0.01% | +20.0% |
| Q4 2020 | $51,063,000 | -39.7% | 2,585,484 | -1.6% | 0.01% | -50.0% |
| Q3 2020 | $84,622,000 | +103.8% | 2,628,020 | +83.7% | 0.01% | +100.0% |
| Q2 2020 | $41,525,000 | +53.3% | 1,430,913 | +10.0% | 0.01% | +25.0% |
| Q1 2020 | $27,094,000 | -15.1% | 1,301,085 | +10.0% | 0.00% | 0.0% |
| Q4 2019 | $31,916,000 | – | 1,183,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |